Functional Changes of Urogenital System After Holmium Laser Prostatectomy
Prospective Cohort Study of Holmium Laser Prostatectomy For Observing Functional Changes in Benign Prostate Hyperplasia Patients
Holmium laser prostatectomy will enhance voiding function.
Holmium laser prostatectomy will enhance sleep quality.
Holmium laser prostatectomy will enhance renal function.
Holmium laser prostatectomy will enhance erectile function.
Holmium laser prostatectomy will enhance the health-related quality of life.
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Seung-Ju Lee, MD, PhD
- Phone Number: 82-31-249-8305
- Email: lee.seungju@gmail.com
Study Locations
-
-
Gyeonggi-do
-
Suwon, Gyeonggi-do, Korea, Republic of, 442-723
- St. Vincent's Hospital, The Catholic University of Korea
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Prostate size over 30 cc by transrectal ultrasonography
- prostate-specific antigen level less than 10 ng/ml
- International prostate symptom score more than 7
- At least one of followings: Bladder outlet obstruction index > 40, maximal flow rate < 10 cc/sec, postvoid residual urine >100cc or schäfer grade II or more
Exclusion Criteria:
- Patients who do not want surgery
- Evidence of prostate cancer or bladder cancer during evaluation or treatment
- All of followings: Bladder outlet obstruction index is less than 40, maximal flow rate is 10 or more cc/sec, postvoid residual urine is less than 100cc and schäfer grade II or less
- Major depressive disorder, Dementia, Parkinson's disease, Neurological deficits
- History of pelvic radiation therapy
- Poorly controlled diabetes mellitus or hypertension
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Maximal flow rate
Time Frame: 3 months
|
This parameter can be obtained from urodynamic study.
|
3 months
|
|
Maximal detrusor pressure
Time Frame: 3 months
|
This parameter can be obtained from urodynamic study.
|
3 months
|
|
Bladder outlet obstruction index
Time Frame: 3 months
|
This parameter can be obtained from urodynamic study.
|
3 months
|
|
schäfer grade
Time Frame: 3 months
|
This parameter can be obtained from urodynamic study.
|
3 months
|
|
Compliance
Time Frame: 3 months
|
This parameter can be obtained from urodynamic study.
|
3 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Maximal flow rate
Time Frame: 12 months
|
This parameter can be obtained from urodynamic study.
|
12 months
|
|
Maximal detrusor pressure
Time Frame: 12 months
|
This parameter can be obtained from urodynamic study.
|
12 months
|
|
Bladder outlet obstruction index
Time Frame: 12 months
|
This parameter can be obtained from urodynamic study.
|
12 months
|
|
schäfer grade
Time Frame: 12 months
|
This parameter can be obtained from urodynamic study.
|
12 months
|
|
Compliance
Time Frame: 12 months
|
This parameter can be obtained from urodynamic study.
|
12 months
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Estimated glomerular filtration rate
Time Frame: 3 months
|
3 months
|
|
|
international index of erectile function
Time Frame: 3 months
|
3 months
|
|
|
international index of erectile function
Time Frame: 12 months
|
12 months
|
|
|
normalized rigidity activity unit in penile tip
Time Frame: 3 months
|
This parameter can be obtained from nocturnal penile tumescence test.
|
3 months
|
|
normalized rigidity activity unit in penile tip
Time Frame: 12 months
|
This parameter can be obtained from nocturnal penile tumescence test.
|
12 months
|
|
normalized rigidity activity unit in penile base
Time Frame: 3 months
|
This parameter can be obtained from nocturnal penile tumescence test.
|
3 months
|
|
Estimated glomerular filtration rate
Time Frame: 12 months
|
12 months
|
|
|
Urinary protein to creatinine ratio
Time Frame: 3 months
|
3 months
|
|
|
Urinary protein to creatinine ratio
Time Frame: 12 months
|
12 months
|
|
|
International prostate symptom score
Time Frame: 3 months
|
3 months
|
|
|
International prostate symptom score
Time Frame: 12 months
|
12 months
|
|
|
Pittsburgh Sleep Quality Index
Time Frame: 3 months
|
3 months
|
|
|
Pittsburgh Sleep Quality Index
Time Frame: 12 months
|
12 months
|
|
|
Health-related quality of life, short form 36 score
Time Frame: 3 months
|
3 months
|
|
|
Health-related quality of life, short form 36 score
Time Frame: 12 months
|
12 months
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Chair: Seung-Ju Lee, The Catholic University of Korea
- Principal Investigator: Dong Sup Lee, The Catholic University of Korea
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- L201401N1
- VC13OISI0222 (Other Identifier: IRB of St. Vincent's Hospital)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.